| Edward Benjamin Penn Jr, MD | |
|
200 Patewood Dr Ste B400, Greenville, SC 29615-6306 | |
| (864) 522-8603 | |
| Not Available |
| Full Name | Edward Benjamin Penn Jr |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 18 Years |
| Location | 200 Patewood Dr Ste B400, Greenville, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053474163 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207YP0228X | Otolaryngology - Pediatric Otolaryngology | 51723 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Prisma Health Greenville Memorial Hospital | Greenville, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Prisma Health University Medical Group | 8325950983 | 2201 |
News Archive
Renal fibrosis, the abnormal accumulation of fibrotic material within the kidney, hinders kidney function and may lead to eventual renal failure.
As medicine becomes more complex and patients live longer and better lives, it also becomes more difficult to keep them safe.
Ocera Therapeutics, Inc. announced today that it has completed two studies evaluating the safety and pharmacokinetics of OCR-002 (ornithine phenylacetate) which includes healthy volunteers and patients with liver cirrhosis. OCR-002 recently received Orphan Drug status and Fast Track designation by the United States Food and Drug Administration for the treatment of hyperammonemia (excessive ammonia levels) and resultant Hepatic encephalopathy.
Health and Social Care Secretary Matt Hancock has announced that the government will begin the process of cross party talks to find a long term solution to funding social care.
The latest research to combat emerging infectious diseases threatening Australia is being presented at the Sydney Institute of Emerging Infectious Diseases and Biosecurity Conference at the University of Sydney today.
› Verified 1 days ago
| Entity Name | Prisma Health University Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295763217 PECOS PAC ID: 8325950983 Enrollment ID: O20031103000238 |
News Archive
Renal fibrosis, the abnormal accumulation of fibrotic material within the kidney, hinders kidney function and may lead to eventual renal failure.
As medicine becomes more complex and patients live longer and better lives, it also becomes more difficult to keep them safe.
Ocera Therapeutics, Inc. announced today that it has completed two studies evaluating the safety and pharmacokinetics of OCR-002 (ornithine phenylacetate) which includes healthy volunteers and patients with liver cirrhosis. OCR-002 recently received Orphan Drug status and Fast Track designation by the United States Food and Drug Administration for the treatment of hyperammonemia (excessive ammonia levels) and resultant Hepatic encephalopathy.
Health and Social Care Secretary Matt Hancock has announced that the government will begin the process of cross party talks to find a long term solution to funding social care.
The latest research to combat emerging infectious diseases threatening Australia is being presented at the Sydney Institute of Emerging Infectious Diseases and Biosecurity Conference at the University of Sydney today.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Edward Benjamin Penn Jr, MD 300 E Mcbee Ave Fl 4, Greenville, SC 29601-2842 Ph: (864) 522-8603 | Edward Benjamin Penn Jr, MD 200 Patewood Dr Ste B400, Greenville, SC 29615-6306 Ph: (864) 522-8603 |
News Archive
Renal fibrosis, the abnormal accumulation of fibrotic material within the kidney, hinders kidney function and may lead to eventual renal failure.
As medicine becomes more complex and patients live longer and better lives, it also becomes more difficult to keep them safe.
Ocera Therapeutics, Inc. announced today that it has completed two studies evaluating the safety and pharmacokinetics of OCR-002 (ornithine phenylacetate) which includes healthy volunteers and patients with liver cirrhosis. OCR-002 recently received Orphan Drug status and Fast Track designation by the United States Food and Drug Administration for the treatment of hyperammonemia (excessive ammonia levels) and resultant Hepatic encephalopathy.
Health and Social Care Secretary Matt Hancock has announced that the government will begin the process of cross party talks to find a long term solution to funding social care.
The latest research to combat emerging infectious diseases threatening Australia is being presented at the Sydney Institute of Emerging Infectious Diseases and Biosecurity Conference at the University of Sydney today.
› Verified 1 days ago
Dr. Augustus J Goforth Iii, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 131 Commonwealth Dr, Suite 230, Greenville, SC 29615 Phone: 864-281-9440 Fax: 864-281-9443 | |
Gustavo Guimaraes Rangel, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 200 Patewood Dr Ste B400, Greenville, SC 29615 Phone: 864-454-4368 Fax: 864-241-9232 | |
Robert A Wilson, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 4200 E North St Ste 16, Greenville, SC 29615 Phone: 864-292-2800 Fax: 864-292-2921 | |
Dr. Ronald T Yuko, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 131 Commonwealth Dr, Suite 290, Greenville, SC 29615 Phone: 864-281-9440 Fax: 864-281-9443 | |
Dr. Robert Lafitte Eller, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1 Doctors Dr, Greenville, SC 29605 Phone: 864-572-7001 Fax: 864-412-0645 | |
Dr. Leighanne Hoskins Dorton, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1 Doctors Dr, Greenville, SC 29605 Phone: 864-572-7001 |